Intended Use For Critical Biopharma Applications 

• Uridine is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring via a β-N1-glycosidic bond. It is one of the five standard nucleosides which make up nucleic acid. Uridine is used as a nutrient, an intermediate in pharmaceutical preparations with other GMP pharmaceutical applications.

General Product Description:

• The manufacturing of Bio Pharma Grade Uridine URID-3250 is performed at BioSpectra’s Bangor, PA facility utilizing multi-use equipment. Equipment used in the manufacturing of URID-3250 is cleaned in accordance with BioSpectra’s Process Cleaning Validation Master Plan.
• Uridine is a White to almost white powder.
• Molecular Formula: C9H12N2O6
• Molecular Weight: 244.20 g/mol.
• CAS Number: 58-96-8
• There are no known major food allergens (as defined by FDA and WHO) in the manufacture of this product.
• BioSpectra certifies that all Uridine, URID-3250 manufactured at BioSpectra and its raw materials are not derived from or come in contact with animal parts, products, and/or byproducts.
• Uridine manufactured at BioSpectra and any raw materials used in the manufacture of Uridine at BioSpectra are not subject to genetic modification.
• Synonyms: 1-β-D-Ribofuranosyluracil, Uracil-1-β-D- ribofuranoside

GMP Compliance:

• Bio Excipient Grade Uridine, URID-3250 is suitable for use as an excipient. It is manufactured in accordance with the ICH-Q7 Good Manufacturing Practice Guide. This grade of Uridine is not suitable to be used as an Active Pharmaceutical Ingredient, Drug Product or Household Item.

Retest Date:

• The recommended retest period for Uridine is two years from the date of manufacture.

Storage and Shipping Conditions:

• Store at ambient temperature.

Package Sizes:

• 10kg, 25kg and 50kg pails.